Skin Diagnosis and Skin Care: Vital Facts and Statistics You Need to Know

Skin cancer is a significant health concern, ranking as the most prevalent cancer both in the United States and globally. Understanding the facts is the first step in proactive Skin Diagnosis Skin Care. This detailed guide, based on the latest research and statistics, provides crucial information to empower you with knowledge for prevention and early detection.

1 in 5 Americans will be diagnosed with skin cancer before turning 70.
Tragically, more than 2 people succumb to skin cancer in the U.S. every hour.
Experiencing 5 or more sunburns significantly elevates your melanoma risk, doubling your chances.
Early skin diagnosis is life-saving: when melanoma is detected and treated in its early stages, the 5-year survival rate soars to 99 percent.

It’s crucial to go beyond surface-level understanding and delve into the comprehensive facts about skin cancer. Knowing these statistics can motivate informed decisions about sun safety, regular skin diagnosis practices, and consistent skin care routines. Share these vital facts and help raise awareness about skin cancer prevention.

Key Skin Cancer Statistics

In the U.S., a staggering number of individuals, exceeding 9,500, receive a skin cancer diagnosis daily. This translates to more than two deaths every hour due to this disease.^1,2,9
Nonmelanoma skin cancers are widespread, with over 5.4 million cases treated in approximately 3.3 million people in the U.S. in 2012. This figure remains the most reliable estimate available.¹
The incidence of skin cancer in the U.S. surpasses the combined incidence of all other cancers each year.²
A concerning statistic reveals that at least one in five Americans will develop skin cancer by the age of 70.³
Actinic keratosis, a common precancerous skin condition, affects over 58 million individuals in the U.S.⁴
The financial burden of treating skin cancers in the U.S. is substantial, estimated at $8.1 billion annually. Nonmelanoma skin cancers account for roughly $4.8 billion, while melanoma treatment costs around $3.3 billion.⁵

Nonmelanoma Skin Cancer: Types and Prevalence

The diagnosis and treatment rates for nonmelanoma skin cancers in the U.S. witnessed a significant surge of 77 percent between 1994 and 2014.⁶
A strong correlation exists between nonmelanoma skin cancers and sun exposure. Approximately 90 percent of these cancers are linked to ultraviolet (UV) radiation from the sun.⁷
Basal cell carcinoma (BCC) stands as the most frequently diagnosed skin cancer. Each year, an estimated 3.6 million cases of BCC are diagnosed in the U.S.^8,1
Squamous cell carcinoma (SCC) is the second most common type of skin cancer. Around 1.8 million SCC cases are diagnosed annually in the U.S.^8,1
Globally, nonmelanoma skin cancer claims thousands of lives monthly. More than 5,400 people worldwide die from nonmelanoma skin cancer every month.²⁷
Organ transplant recipients face a significantly elevated risk of developing squamous cell carcinoma, being approximately 100 times more likely than the general population.¹⁰
Sunscreen plays a vital role in prevention. Consistent daily use of an SPF 15 or higher sunscreen, when applied correctly, can reduce the risk of developing squamous cell carcinoma by about 40 percent.¹¹
Merkel cell carcinoma, a less common but aggressive type, affects around 3,000 new individuals in the U.S. each year, with a recurrence rate of about 40 percent. ⁴³

Melanoma: Facts, Risks, and Survival Rates

Melanoma incidence is projected to rise. Estimates suggest a 5.9 percent increase in new melanoma diagnoses by 2025.^2,42
Melanoma deaths are also expected to increase, with a projected rise of 1.7 percent in 2025.^2,42
A significant number of melanoma cases are anticipated in the U.S. in 2025, estimated at 212,200. Of these, 107,240 are expected to be in situ (noninvasive), confined to the epidermis, and 104,960 will be invasive, penetrating deeper into the skin. Invasive cases are further broken down with approximately 60,550 in men and 44,410 in women.²
Invasive melanoma diagnoses are on the rise. Over the past decade (2015 – 2025), the annual number of new invasive melanoma cases has increased by a significant 42 percent.^2,39
Melanoma mortality remains a serious concern. An estimated 8,430 deaths from melanoma are projected for 2025, with 5,470 in men and 2,960 in women.²

Early skin diagnosis through regular self-exams and professional checks is critical in identifying potentially cancerous moles.

Sunlight is the primary culprit behind most melanomas. A UK study indicated that approximately 86 percent of melanomas are attributed to UV radiation exposure from the sun.¹²
Timely treatment is crucial for melanoma survival. Compared to stage I melanoma patients treated within 30 days of biopsy, those treated between 30 to 59 days later have a 5 percent higher mortality risk, and those treated after 119 days face a 41 percent higher risk.¹³
Survival rates for melanoma are highly stage-dependent. Data from 2014 – 2020 indicates an average five-year survival rate of 94 percent across all melanoma stages in the U.S. For early-stage melanoma, the five-year survival rate exceeds 99 percent. However, this rate drops to 75 percent when the cancer reaches lymph nodes and further to 35 percent when it metastasizes to distant organs.²
Most melanomas arise from new spots, not existing moles. Only 20 to 30 percent of melanomas develop from pre-existing moles, while 70 to 80 percent appear on seemingly normal skin.¹⁴
Sunburn history significantly increases melanoma risk. On average, having more than five sunburns doubles a person’s risk of developing melanoma.¹⁵
Sunscreen offers substantial protection against melanoma. Regular daily use of an SPF 15 or higher sunscreen reduces melanoma risk by 50 percent.¹⁶
Melanoma incidence varies by gender. Melanoma accounts for 6 percent of new cancer cases in men and 4 percent in women.²
Age and gender influence melanoma risk. Men age 49 and under have a higher likelihood of developing melanoma compared to any other cancer except colon and rectum cancers.²
Young men face higher melanoma mortality. From ages 15 to 39, men are 55 percent more likely to die from melanoma than women in the same age group.¹⁷
Young women are also at risk. Women age 49 and under are more prone to developing melanoma than any other cancer except breast and thyroid cancers.²
Melanoma incidence shifts with age. From age 50 onwards, melanoma becomes significantly more common in men than women. However, until age 49, non-Hispanic white women are diagnosed with melanoma more frequently than white men (one in 162 women versus one in 258 men). Overall, the lifetime risk of melanoma is one in 29 for white men and one in 40 for white women.²

The Dangers of Indoor Tanning

UV radiation from indoor tanning is a proven human carcinogen.¹⁸
The International Agency for Research on Cancer, a part of the World Health Organization, classifies UV tanning devices in its Group 1, the highest risk category for cancer-causing agents. This group also includes substances like plutonium, cigarettes, and solar UV radiation.¹⁹
Regulatory bodies recognize the risks of indoor tanning. The FDA reclassified UV tanning devices from Class I (low risk) to Class II (moderate to high risk) in 2014.²⁰
Indoor tanning beds emit intense UV radiation. These devices can produce UV radiation 10 to 15 times stronger than the midday sun.⁴¹
Many regions restrict or ban indoor tanning for minors. Twenty states and the District of Columbia prohibit individuals under 18 from using indoor tanning devices. Oregon and Washington require a prescription for those under 18.²¹
Some countries have completely banned indoor tanning. Australia, Brazil, and Iran have implemented nationwide bans on indoor tanning.²²

Indoor tanning significantly increases skin cancer risk, emphasizing the importance of skin care education, especially for younger individuals.

The economic burden of indoor tanning-related skin cancer is substantial. Direct medical costs for skin cancer cases linked to indoor tanning amount to $343.1 million annually in the U.S.²³
Indoor tanning leads to numerous skin cancer cases. Over 419,000 skin cancer cases in the U.S. each year are attributed to indoor tanning, including approximately 245,000 basal cell carcinomas, 168,000 squamous cell carcinomas, and 6,200 melanomas.²⁴
Indoor tanning is a greater cancer risk factor than smoking for lung cancer. More people develop skin cancer due to indoor tanning than lung cancer from smoking.²⁴
Indoor tanning history significantly elevates skin cancer risk. Individuals who have ever tanned indoors have an 83 percent increased risk of squamous cell carcinoma⁴³ and a 29 percent increased risk of basal cell carcinoma.²⁴
Early indoor tanning increases basal cell carcinoma risk. Any history of indoor tanning increases the risk of developing basal cell carcinoma before age 40 by 69 percent.²⁵
Young women who tan indoors face a dramatically increased melanoma risk. Women who have ever tanned indoors are six times more likely to be diagnosed with melanoma in their 20s compared to those who have never tanned indoors. The more women tan indoors across all ages, the higher their melanoma risk.²⁶
Tanning bed use is strongly linked to melanoma in young women. A study of 63 women diagnosed with melanoma before age 30 found that 61 (97 percent) had used tanning beds.²⁶
Early tanning bed use dramatically increases melanoma risk. People who first use a tanning bed before age 35 increase their risk of melanoma by 75 percent.²⁸
Indoor tanning among teenagers is decreasing. Indoor tanning among U.S. high school students decreased by 53 percent between 2009 and 2015, indicating positive trends in awareness.²⁹

Skin Aging and Sun Exposure

Sunlight is a major contributor to visible skin aging. An estimated 80 percent of visible skin aging in Caucasian women is attributed to sun exposure.³⁰
Sunscreen effectively reduces skin aging. Daily sunscreen use with SPF 15 or higher shows 24 percent less skin aging compared to those who don’t use sunscreen daily.³¹
Sun damage accumulates over time. Only about 23 percent of lifetime sun exposure occurs by age 18, highlighting the importance of lifelong sun protection habits.³²

Ages	Average Accumulated Sun Exposure*
1-18	23 percent
19-40	47 percent
41-59	74 percent
60-78	100 percent
Based on a 78-year life span

Skin Cancer and Ethnicity

Melanoma survival rates vary significantly by ethnicity. Based on data from 2014 – 2020, the estimated five-year melanoma survival rate for Black patients is only 70 percent, compared to 94 percent for white patients, highlighting disparities in outcomes.²
Skin cancer incidence differs across ethnic groups. Skin cancer accounts for approximately 2 to 4 percent of all cancers in Asian people.³³
Skin cancer prevalence in Hispanic populations. Skin cancer represents 4 to 5 percent of all cancers in Hispanic people.³⁵
Skin cancer is less common in Black populations but still a concern. Skin cancer represents 1 to 2 percent of all cancers in Black people.³³
Melanoma location varies by ethnicity. Melanomas in Black people, Asian people, and native Hawaiians often occur on less sun-exposed skin with less pigment, such as palms, soles, mucous membranes, and nail regions, in up to 60 to 75 percent of cases.³³
Foot cancer is a significant concern for non-white populations. In nonwhite individuals, the plantar aspect of the foot is frequently the most common site for skin cancer, involved in 30 to 40 percent of cases.³⁵
Squamous cell carcinoma is the most common skin cancer in Black people.³³
Late-stage diagnosis is more frequent in certain ethnic groups. Late-stage melanoma diagnoses are more prevalent among Hispanic and Black people compared to non-Hispanic white people. 52 percent of non-Hispanic black patients and 26 percent of Hispanic patients receive an initial diagnosis of advanced-stage melanoma, versus 16 percent of non-Hispanic white patients, contributing to poorer prognoses.³⁴
Acral lentiginous melanoma (ALM) is more common in people of color. People of color have higher percentages of acral lentiginous melanoma (ALM, melanoma of the palms, soles, and nail beds) than Caucasian people. Superficial spreading melanoma is the most frequent subtype in Caucasian and Hispanic populations.³⁵

Pediatric Skin Cancer

Childhood melanoma is rare but serious. Melanoma in children and adolescents represents a small percentage of all new melanoma cases in the United States, with approximately 300 cases per year in children under 20.³⁶
Pediatric melanoma as a proportion of childhood cancers. Melanoma in children and adolescents constitutes 3 percent of all pediatric cancers in the United States.³⁷
Diagnosis delays in childhood melanoma are common. Treatment for childhood melanoma is often delayed due to misdiagnosis of pigmented lesions, occurring in up to 40 percent of cases, emphasizing the need for improved skin diagnosis awareness among pediatricians.³⁹

Conclusion: Prioritizing Skin Diagnosis and Skin Care

Understanding these skin cancer facts and statistics underscores the critical importance of proactive skin diagnosis skin care. Regular self-skin exams, annual professional skin checks, and diligent sun protection are not just lifestyle choices; they are essential steps in safeguarding your health. Early skin diagnosis dramatically improves survival rates, particularly for melanoma. By staying informed and adopting preventive skin care habits, you can significantly reduce your risk and contribute to a healthier future. Share this information, encourage regular skin diagnosis, and promote sun-safe behaviors to help combat skin cancer effectively.

References

Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Dermatol 2015; 151(10):1081-1086.
Cancer Facts and Figures 2025. American Cancer Society. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2025/2025-cancer-facts-and-figures-acs.pdf Accessed January 21, 2025.
Stern, RS. Prevalence of a history of skin cancer in 2007: results of an incidence-based model. Arch Dermatol 2010; 146(3):279-282.
The Lewin Group, Inc. The Burden of Skin Diseases 2005. Prepared for the Society for Investigative Dermatology, Cleveland, OH, and the American Academy of Dermatology Assn., Washington, DC, 2005.
Guy GP, Machlin SR, Ekwueme DU, Yabroff KR. Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011. Am J Prev Med 2015; 48(2):183-187. doi: 10.1016/j.amepre.2014.08.036.
Mohan SV, Chang AL. Advanced basal cell carcinoma: epidemiology and therapeutic innovations. Curr Dermatol Rep 2014; 3(1):40-45. doi:10.1007/s13671-014-0069-y.
Koh HK, Geller AC, Miller DR, et al. Prevention and early detection strategies for melanoma and skin cancer: Current status. Arch Dermatol 1996; 132(4):436-442.
Our New Approach to a Challenging Skin Cancer Statistic. The Skin Cancer Foundation. https://www.skincancer.org/blog/our-new-approach-to-a-challenging-skin-cancer-statistic/. Accessed January 20, 2024.
Mansouri B, Housewright C. The treatment of actinic keratosesâ€”the rule rather than the exception. J Am Acad Dermatol 2017; 153(11):1200. doi:10.1001/jamadermatol.2017.3395.
LindelÃ¶f B, Sigurgeirsson B, GÃ¤bel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143(3):513-9.
Green A, Williams G, Neale R, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomized controlled trial. The Lancet 1999; 354(9180):723-729.
Parkin DM, Mesher D, Sasieni P. Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010. Br J Cancer 2011; 105:S66-S69.
Conic RZ, Cabrera CI, Khorana AA, Gastman BR. Determination of the impact of melanoma surgical timing on survival using the National Cancer Database. J Am Acad Dermatol 2018; 78(1):40-46.e7. doi:10.1016/j.jaad.2017.08.039.
Cymerman RM, Shao Y, Wang K, et al. De novo versus nevus-associated melanomas: Differences in associations with prognostic indicators and survival. J Natl Cancer Inst 2016 May 27; 108(10). doi:10.1093/jnci/djw121.
Pfahlberg A, KÃ¶lmel KF, Gefeller O. Timing of excessive ultraviolet radiation and melanoma: epidemiology does not support the existence of a critical period of high susceptibility to solar ultraviolet radiation-induced melanoma. Br J Dermatol 2001; 144:3:471-475.
Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol 2011; 29(3):257-263.
Fisher DE, Geller AC. Disproportionate burden of melanoma mortality in young US men. JAMA Dermatol 2013; 149(8): 903. doi:10.1001/jamadermatol.20134437.
Ultraviolet-radiation-related exposures. Broad-spectrum UVR, pp. 1-5. NTP (National Toxicology Program). 2014. Report on Carcinogens, Thirteenth Edition. Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service. http://ntp.niehs.nih.gov/ntp/roc/content/profiles/ultravioletradiationrelatedexposures.pdf. Accessed January 26, 2018.
El Ghissassi F, Baan R, Straif K, et al. Special report: policy. A review of human carcinogensâ€”part D: radiation. The Lancet 2009; 10(8):751-752. doi: https://doi.org/10.1016/S1470-2045(09)70213-X.
Tanning Lamps, Booths and Beds. Food and Drug Administration. https://www.fda.gov/radiation-emitting-products/tanning/tanning-products. Accessed January 30,2024.
Indoor tanning restrictions for minors. AIM at Melanoma. https://www.aimatmelanoma.org/legislation-policy-advocacy/indoor-tanning/. Accessed January 30,2024.
Mathes S, Lindwedel KS, Nilsen LT, Kaiser I, Pfahlberg AB, Gefeller O. Global Tanning Bed Advertising: A Comparison of Legal Regulations on Three Continents. Cancers (Basel). 2023;15(17):4362. Published 2023 Sep 1. doi: 3390/cancers15174362
Waters HR, Adamson A. The health and economic implications of the use of tanning devices. J Cancer Policy 2017; http://dx.doi.org/10.1016/j.jcpo.2016.12.003.
Wehner MR, Chren MM, Nameth D, et al. International prevalence of indoor tanning: a systematic review and meta-analysis. JAMA Dermatol 2014; 150(4):390-400. doi:10.1001/jamadermatol.2013.6896.
Ferrucci LM, Cartmel B, Molinaro AM, et al. Indoor tanning and risk of early-onset basal cell carcinoma. J Am Acad Dermatol 2012 Oct; 67(4):552-62. doi:10.1016/j.jaad.2011.11.940.
Lazovich D, Vogel RI, Weinstock MA, et al. Association between indoor tanning and melanoma in younger men and women. JAMA Dermatol 2016; 152(3): 268â€“275. doi:10.1001/jamadermatol.2015.2938
Global Burden of Disease Cancer Collaboration. Global, regional and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017. JAMA Oncol. 2019;5(12):1749-1768. doi:10.1001/jamaoncol.2019.2996.
The International Agency for Research on Cancer Working Group. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int J Canc 2006; 120:1116-1122.
Guy GP Jr, Berkowitz Z, Everett Jones S, et al. Prevalence of indoor tanning and association with sunburn among youth in the United States. JAMA Dermatol 2017; 153(5):387-390. doi:10.1001/jamadermatol.2016.6273.
Flament F, Bazin R, Laquieze S, Rubert V, Simonpietri E, Piot B. Effect of the sun on visible clinical signs of aging in Caucasian skin. Clin Cosmet Investig Dermatol. 2013;6:221-232. Published 2013 Sep 27. doi:10.2147/CCID.S44686Hughes MCB, Williams GM, Baker P, Green AC. Sunscreen and prevention of skin aging: a randomized trial. Ann Intern Med 2013; 158(11):781-790.
Godar DE, Urbach F, Gasparro FP, van der Leun JC. UV doses of young adults. Photochem Photobiol 2003; 77(4):453-7.
Gloster HM, Neal K. Skin cancer in skin of color. J Am Acad Dermatol 2006; 55:741-60.
Hu S, Soza-Vento RM, Parker DF, et al. Comparison of stage at diagnosis of melanoma among Hispanic, black, and white patients in Miami-Dade County, Florida. Arch Dermatol 2006; 142(6):704-8.
Bradford, Porcia T. Skin Cancer in Skin of Color. Dermatol Nurs 2009 Jul-Aug; 21(4): 170-178.
Childhood Melanoma Treatment (PDQ) â€“ Health Professional Version. National Cancer Institute. https://www.cancer.gov/types/skin/hp/child-melanoma-treatment-pdq. Accessed January 30, 2024.
Han D, Zager JS, Han G, et al. The unique clinical characteristics of melanoma diagnosed in children. Ann Surg Oncol. 2012;19(12):3888â€“3895. doi:10.1245/s10434-012-2554-5
Paulson KG, Gupta D, Kim TS, et al. Age-specific incidence of melanoma in the United States. JAMA Dermatol. 2020; 156(1):57â€“64. doi:10.1001/jamadermatol.2019.3353
Ferrari A, Bono A, Baldi M, et al. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics 2005; 115(3):649-57.
Cancer Facts and Figures 2015. American Cancer Society. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2015.html. Accessed January 21, 2025.
Le Clair MZ, Cockburn MG. Tanning bed use and melanoma: Establishing risk and improving prevention interventions. Prev Med Rep. 2016; 3:139â€“144. Published 2016 Jan 14. doi: 10.1016/j.pmedr.2015.11.016
McEvoy AM, Lachance K, Hippe DS, et al. Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis. JAMA Dermatol. 2022;158(4):382-389. doi:10.1001/jamadermatol.2021.6096
Cancer Facts and Figures 2024. American Cancer Society. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2024-cancer-facts-figures.html Accessed January 21, 2025.
Cancer Facts and Figures 2024. American Cancer Society. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2024-cancer-facts-figures.html Accessed January 21, 2025.

Last updated: January 2025